Yiheng Capital Management, L.P. Denali Therapeutics Inc. Transaction History
Yiheng Capital Management, L.P.
- $1.02 Billion
- Q1 2025
A detailed history of Yiheng Capital Management, L.P. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Yiheng Capital Management, L.P. holds 469,981 shares of DNLI stock, worth $6.21 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
469,981
Previous 469,981
-0.0%
Holding current value
$6.21 Million
Previous $6.39 Million
-0.0%
% of portfolio
0.63%
Previous 0.63%
Shares
6 transactions
Others Institutions Holding DNLI
# of Institutions
231Shares Held
128MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$174 Million0.01% of portfolio
-
Baillie Gifford & CO12MShares$158 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$156 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$151 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$89.5 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.77B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...